{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:29:57Z","timestamp":1787243397480,"version":"build-2736575974"},"reference-count":50,"publisher":"Codon Publications","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergologia et Immunopathologia"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.aller.2019.08.005","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T19:48:27Z","timestamp":1575920907000},"page":"409-413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["CD40 Ligand Deficiency"],"prefix":"10.15586","volume":"48","author":[{"given":"L.F.B.","family":"Leite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.A.","family":"M\u00e1ximo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Mosca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.C.N.","family":"Forte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6228","reference":[{"key":"10.1016\/j.aller.2019.08.005_bib0005","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10875-017-0465-8","article-title":"The 2017 IUIS phenotypic classification for primary immunodeficiencies","volume":"38","author":"Bousfiha","year":"2018","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.aller.2019.08.005_bib0010","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1203\/01.PDR.0000139318.65842.4A","article-title":"The hyper IgM syndrome \u2014 an evolving story","volume":"56","author":"Etzioni","year":"2004","journal-title":"Pediatr Res"},{"key":"10.1016\/j.aller.2019.08.005_bib0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.clim.2018.07.013","article-title":"Clinical and molecular features of X-linked hyper IgM syndrome \u2014 an experience from North India","volume":"195","author":"Rawat","year":"2018","journal-title":"Clin Immunol"},{"key":"10.1016\/j.aller.2019.08.005_bib0020","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1542\/peds.28.2.182","article-title":"Recurrent bacterial infections and dysgamma-globulinemia: deficiency of 7S gamma-globulins in the presence of elevated 19S gamma-globulins. Report of two cases","volume":"28","author":"Rosen","year":"1961","journal-title":"Pediatrics"},{"key":"10.1016\/j.aller.2019.08.005_bib0025","first-page":"286","article-title":"An example of atypical agammaglobulinemia (a case of severe hypogammaglobulinemia with increase of the beta-2 macroglobulin)","volume":"6","author":"Burtin","year":"1961","journal-title":"Rev Fr Etud Clin Biol"},{"key":"10.1016\/j.aller.2019.08.005_bib0030","series-title":"Disserta\u00e7\u00e3o de mestrado) Instituto de Ci\u00eancias Biol\u00f3gicas da USP","first-page":"111","article-title":"Defeitos gen\u00e9tico-moleculares e aspectos cl\u00ednicos de pacientes com s\u00edndrome de Hiper IgM autoss\u00f4mica","author":"Klaver","year":"2011"},{"key":"10.1016\/j.aller.2019.08.005_bib0035","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0091-6749(05)80116-2","article-title":"Variable expression of IgG2 deficiency","volume":"86","author":"Kavanaugh","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2019.08.005_bib0040","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jaci.2006.01.043","article-title":"Defects of class-switch recombination","volume":"117","author":"Notarangelo","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2019.08.005_bib0045","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.md.0000100046.06009.b0","article-title":"The X-linked hyper-IgM syndrome. Clinical and immunologic features of 79 patients","volume":"82","author":"Winkelstein","year":"2003","journal-title":"Medicine"},{"key":"10.1016\/j.aller.2019.08.005_bib0050","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.0105-2896.2005.00229.x","article-title":"Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features","volume":"203","author":"Lougaris","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.aller.2019.08.005_bib0055","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0092-8674(00)00079-9","article-title":"Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2)","volume":"102","author":"Revy","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.aller.2019.08.005_bib0060","doi-asserted-by":"crossref","first-page":"11554","DOI":"10.1073\/pnas.1102600108","article-title":"Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humans","volume":"108","author":"Meyers","year":"2011","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.aller.2019.08.005_bib0065","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0065-2776(10)05006-6","article-title":"AID and somatic hypermutation","volume":"105","author":"Maul","year":"2010","journal-title":"Adv Immunol"},{"key":"10.1016\/j.aller.2019.08.005_bib0070","doi-asserted-by":"crossref","first-page":"683160","DOI":"10.1155\/2014\/683160","article-title":"Clinical features and genetic analysis of 20 Chinese patients with X-linked hyper-IgM syndrome","volume":"2014","author":"Wang","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.aller.2019.08.005_bib0075","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jaip.2016.09.013","article-title":"Clinical phenotypes of hyper-IgM syndromes","volume":"4","author":"de la Morena","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.aller.2019.08.005_bib0080","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/INF.0b013e3182936280","article-title":"Clinical features and genetic analysis of Taiwanese patients with the hyper IgM syndrome phenotype","volume":"32","author":"Lee","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.aller.2019.08.005_bib0085","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000142050","article-title":"Severe congenital neutropenia or hyper-IgM syndrome? A novel mutation of CD40 ligand in a patient with severe neutropenia","volume":"147","author":"Rezaei","year":"2008","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.aller.2019.08.005_bib0090","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.clim.2010.01.012","article-title":"Immunoglobulin class switch recombination deficiencies","volume":"135","author":"Kracker","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.aller.2019.08.005_bib0095","first-page":"127","article-title":"Molecular processes that regulate class switching","volume":"245","author":"Stavnezer","year":"2000","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.aller.2019.08.005_bib0100","series-title":"Alergia e imunologia na inf\u00e2ncia e na adolesc\u00eancia","first-page":"533","article-title":"Imunodefici\u00eancias predominantemente humorais","author":"Grumach","year":"2009"},{"key":"10.1016\/j.aller.2019.08.005_bib0105","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1097\/MPH.0b013e318241fa1b","article-title":"X-linked hyper IgM syndrome: a novel sequence variant associated with an atypical mild phenotype","volume":"34","author":"Buchbinder","year":"2012","journal-title":"J Pediat Hematol Onc"},{"key":"10.1016\/j.aller.2019.08.005_bib0110","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nri3216","article-title":"Immunoglobulin class-witch DNA recombination: induction, targeting and beyond","volume":"12","author":"Xu","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.aller.2019.08.005_bib0115","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s10875-011-9607-6","article-title":"Phenotypic heterogeneity in a family with a CD40 ligand intracellular domain mutation","volume":"32","author":"Kiani-Alikan","year":"2012","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.aller.2019.08.005_bib0120","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0167-5699(96)80904-2","article-title":"CD40lbase: a database of CD40L gene mutations causing X-linked hyper IgM syndrome","volume":"17","author":"Notarangelo","year":"1996","journal-title":"Immunol Today"},{"key":"10.1016\/j.aller.2019.08.005_bib0125","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2147\/ITT.S163614","article-title":"Multiple effects of CD40-CD40L axis in immunity against infection and cancer","volume":"7","author":"Ara","year":"2018","journal-title":"Immunotargets Ther"},{"key":"10.1016\/j.aller.2019.08.005_bib0130","series-title":"Imunologia do b\u00e1sico ao aplicado","first-page":"51","article-title":"Imunoglobulinas","author":"Forte","year":"2015"},{"key":"10.1016\/j.aller.2019.08.005_bib0135","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/biof.62","article-title":"CD40\/CD40L signaling and its implication in health and disease","volume":"35","author":"Chatzigeorgiou","year":"2009","journal-title":"Biofactors"},{"key":"10.1016\/j.aller.2019.08.005_bib0140","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s10875-015-0202-0","article-title":"Late-onset combined immunodeficiency with novel IL2RG mutation and probable revertant somatic mosaicism","volume":"35","author":"Okuno","year":"2015","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.aller.2019.08.005_bib0145","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jaci.2016.07.018","article-title":"Human CD40 ligand deficiency dysregulatesthe macrophage transcriptome causing functional defects that are improved by exogenous IFN-y","volume":"139","author":"Cabral-Marques","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2019.08.005_bib0150","unstructured":"BRAGID. Brazilian Group for Immunodeficiencies. Acessado em 8\/setembro\/2018. In: http:\/\/www.imunopediatria.org.br."},{"key":"10.1016\/j.aller.2019.08.005_bib0155","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1182\/blood-2011-04-351254","article-title":"Partial immune reconstitution of X-linked hyper IgM syndrome with recombinant CD40 ligand","volume":"118","author":"Jain","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.aller.2019.08.005_bib0160","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1067\/mpd.2003.41","article-title":"Disseminated cryptosporidium infection in an infant with hyper-IgM syndrome caused by CD40 deficiency","volume":"142","author":"Kutukculer","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.aller.2019.08.005_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fped.2018.00130","article-title":"A novel de novo mutation in the CD40 ligand gene in a patient with a mild X-Linked hyper-IgM phenotype initially diagnosed as CIVD: New aspects of old diseases","volume":"6","author":"Fran\u00e7a","year":"2018","journal-title":"Front Pediatr"},{"key":"10.1016\/j.aller.2019.08.005_bib0170","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","article-title":"Molecular mechanism and function of CD40\/CD40L engagement in the immune system","volume":"229","author":"Elgueta","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.aller.2019.08.005_bib0175","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s10875-013-9980-4","article-title":"First report of the Hyper-IgM syndrome registry of the Latin America Society for Immunodeficiencies: Novel mutations, unique infections and outcomes","volume":"34","author":"Cabral-Marques","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.aller.2019.08.005_bib0180","series-title":"Alergia e Imunologia cl\u00ednica: aplica\u00e7\u00e3o cl\u00ednica","first-page":"294","article-title":"Imunodefici\u00eancias prim\u00e1rias","author":"Kokron","year":"2015"},{"key":"10.1016\/j.aller.2019.08.005_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/s1679-45082017ae3844","article-title":"II Consenso Brasileiro sobre o uso de imunoglobulina humana em pacientes com imunodefici\u00eancias prim\u00e1rias","volume":"15","author":"Goudouris","year":"2017","journal-title":"Rev Einstein"},{"key":"10.1016\/j.aller.2019.08.005_bib0190","first-page":"7","article-title":"Triagem neonatal para imunodefici\u00eancia combinada grave","volume":"34","author":"Kanegae","year":"2011","journal-title":"Rev Bras Alerg Imunopatol"},{"key":"10.1016\/j.aller.2019.08.005_bib0195","first-page":"239","article-title":"The efficacy of immunoglobulin replacement therapy in the long-term follow-up of the B-cell deficiencies (XLA, HIM, CVID)","volume":"47","author":"Bayrakci","year":"2005","journal-title":"Turk J Ped"},{"key":"10.1016\/j.aller.2019.08.005_bib0200","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/ajh.20044","article-title":"Allogeneic hematopoietic stem cell transplantation for seven children With X-linked hyper-IgM syndrome: a single center experience","volume":"76","author":"Tomizawa","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.aller.2019.08.005_bib0205","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1111\/ajt.13580","article-title":"Liver transplantation in a patient with CD40 ligand deficiency and hyper-IgM syndrome: clinical and immunological assessments","volume":"16","author":"Tseng","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.aller.2019.08.005_bib0210","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.4049\/jimmunol.168.3.1473","article-title":"CD40 ligand-deficient t cells from X-linked hyper-IgM syndrome carriers have intrinsic priming capability","volume":"168","author":"Lobo","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.aller.2019.08.005_bib0215","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1067\/mpd.2001.112511","article-title":"Unrelated umbilical cord stem cell transplantation for X-linked immunodeficiencies","volume":"138","author":"Ziegner","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.aller.2019.08.005_bib0220","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jaci.2010.06.015","article-title":"Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?","volume":"126","author":"Gennery","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2019.08.005_bib0225","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s10875-016-0291-4","article-title":"Hyper IgM syndrome: A report from the USIDNET regist","volume":"36","author":"Leven","year":"2016","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.aller.2019.08.005_bib0230","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2567.2006.02520.x","article-title":"Hyper-immunoglobulin M syndrome caused by a mutation in the promotor for CD40L. Blackwell Publishing Ltd","volume":"120","author":"Hoeyveld","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.aller.2019.08.005_bib0235","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1590\/S0103-05822011000400032","article-title":"Relato de um caso de neutropenia cong\u00eanita grave em um lactente jovem","volume":"29","author":"Santos","year":"2011","journal-title":"Rev Paul Pediatr"},{"key":"10.1016\/j.aller.2019.08.005_bib0240","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.jaci.2018.02.026","article-title":"CD40 ligand deficiency causes functional defects of peripheral neutrophils that are improved by exogenous IFN-\u03b3","volume":"142","author":"Cabral-Marques","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2019.08.005_bib0245","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jaci.2013.11.043","article-title":"Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts","volume":"133","author":"Shearer","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2019.08.005_bib0250","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jaci.2017.12.980","article-title":"Update: vaccines in primary immunodeficiency","volume":"141","author":"Bonilla","year":"2018","journal-title":"J Allergy Clin Immunol"}],"container-title":["Allergologia et Immunopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301054619301429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301054619301429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T21:19:28Z","timestamp":1665177568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301054619301429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0301054619301429"],"URL":"https:\/\/doi.org\/10.1016\/j.aller.2019.08.005","relation":{},"ISSN":["0301-0546"],"issn-type":[{"value":"0301-0546","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD40 Ligand Deficiency","name":"articletitle","label":"Article Title"},{"value":"Allergologia et Immunopathologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aller.2019.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 SEICAP. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}